You have 6 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Glycogen Storage Disease II

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pompe Disease, Muscle Loss, Obesity Trial (Multi-ingredient supplement (PDT-MIS), Placebo (PLA))

Not yet recruiting
  • Pompe Disease
  • +7 more
  • Multi-ingredient supplement (PDT-MIS)
  • Placebo (PLA)
  • (no location specified)
Nov 8, 2023

Carbon-13 Magnetic Resonance Spectroscopy in Glycogen Storage

Recruiting
  • Glycogen Storage Disease
  • +2 more
  • No intervention
  • Copenhagen, Copenhange, Denmark
    Neuromuscular Research Unit, 8077
Oct 26, 2022

Pompe Disease -Non-invasive Magnetic Resonance Exploratory Pilot

Not yet recruiting
  • Pompe Disease
  • McArdle Disease
  • Siemens Magnetom 7T Plus
  • Vienna, Austria
    Medical University of Vienna
Jul 5, 2023

Pompe Disease, Glycogen Storage Disease Type II (GSD-II), Acid Maltase Deficiency Disease Trial in Gainesville, Decatur, Detroit

Completed
Has Results
  • Pompe Disease
  • +2 more
  • alglucosidase alfa
  • Gainesville, Florida
  • +2 more
Jul 29, 2022

Pompe Telemedicine Developmental Study

Completed
  • Pompe Disease
  • Glycogen Storage Disease II
    • Durham, North Carolina
      Duke University Medical Center
    Oct 27, 2021

    Glycogen Storage Disease Type II, Pompe Disease (Late-onset) Trial in Milan (Inspiratory Muscle Training (IMT), Inspiratory

    Recruiting
    • Glycogen Storage Disease Type II
    • Pompe Disease (Late-onset)
    • Inspiratory Muscle Training (IMT)
    • Inspiratory Muscle Training (IMT) + Air Stacking
    • Milan, Italy
      IRCCS S. Maria Nascente - Fondazione Don Carlo Gnocchi
    Jul 11, 2023

    Glycogen Storage Disease Type II Infantile Onset Trial in Gainesville (Cipaglucosidase alfa (ATB200), Miglustat (AT2221))

    Recruiting
    • Glycogen Storage Disease Type II Infantile Onset
    • Gainesville, Florida
      University of Florida Clinical Research Center
    Jan 18, 2023

    Pompe Disease (Late-onset) Trial (No Intervention)

    Not yet recruiting
    • Pompe Disease (Late-onset)
    • No Intervention
    • (no location specified)
    Nov 21, 2023

    Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis IV A Trial in San Francisco (There is no intervention)

    Recruiting
    • Mucopolysaccharidosis I
    • +7 more
    • There is no intervention
    • San Francisco, California
      University of California San Francisco
    Nov 9, 2022

    Natural History of Pompe Disease

    Recruiting
    • Glycogen Storage Disease Type II, Adult
      • Garches, Hauts-de-Seine, France
        Hôpital Raymond Poincaré
      Apr 20, 2022

      Glycogen Storage Disease Type II Trial in Worldwide (Alglucosidase alfa GZ419829)

      Recruiting
      • Glycogen Storage Disease Type II
      • Alglucosidase alfa GZ419829
      • Leuven, Belgium
      • +8 more
      Jan 17, 2023

      Pompe Disease, Glycogen Storage Disease Type II (GSD-II), Glycogenesis 2 Acid Maltase Deficiency Trial in Israel, United States

      Terminated
      Has Results
      • Pompe Disease
      • +2 more
      • Myozyme® (alglucosidase alfa)
      • Louisville, Kentucky
      • +4 more
      Mar 24, 2022

      Pompe Disease Trial in New York, Fairfax (biological, drug, other)

      Not yet recruiting
      • Pompe Disease
      • Cipaglucosidase alfa
      • +3 more
      • New York, New York
      • +1 more
      Nov 2, 2023

      Glycogen Storage Disease Type II Trial in France (Avalglucosidase alfa (GZ402666))

      Recruiting
      • Glycogen Storage Disease Type II
      • Avalglucosidase alfa (GZ402666)
      • Brest, France
      • +9 more
      Jul 22, 2022

      ERT in Pompe Disease: Elucidation of Molecular Structures

      Not yet recruiting
      • Pompe-Disease
        • Rüsselsheim, Hessen, Germany
          Centre for Analytical Biochemistry
        Jan 30, 2023

        Pompe Disease (Late-onset) Trial in Durham (Clenbuterol, Placebos)

        Withdrawn
        • Pompe Disease (Late-onset)
        • Durham, North Carolina
          Duke University Medical Center
        Aug 15, 2022

        Cognitive and Neurological Pathologies in Pompe Disease

        Recruiting
        • Pompe Disease
          • Durham, North Carolina
            Duke University Medical Center
          Jun 30, 2022

          Glycogen Storage Disease Type II Trial in Worldwide (avalglucosidase alfa)

          Recruiting
          • Glycogen Storage Disease Type II
          • avalglucosidase alfa
          • Leuven, Belgium
          • +7 more
          Jul 13, 2022

          Pompe Disease, Pompe Disease (Late-onset), Pompe's Disease Juvenile Onset Trial in Erlangen (Multispectral Optoacoustic

          Recruiting
          • Pompe Disease
          • +3 more
          • Multispectral Optoacoustic Tomography
          • Erlangen, Bavaria, Germany
            University Hospital Erlangen
          Jun 2, 2022

          Glycogen Storage Disease Type II Pompe Disease Trial in Worldwide (GZ402666)

          Completed
          • Glycogen Storage Disease Type II Pompe Disease
          • Phoenix, Arizona
          • +16 more
          Dec 14, 2022

          Pompe's Disease Trial in China (ALGLUCOSIDASE ALFA)

          Recruiting
          • Pompe's Disease
          • ALGLUCOSIDASE ALFA
          • China, China
            Investigational Site
          Oct 26, 2022

          Late-onset Pompe Disease Trial in Gainesville, London (Respiratory muscle strength measurements by different techniques.)

          Terminated
          Has Results
          • Late-onset Pompe Disease
          • Respiratory muscle strength measurements by different techniques.
          • Gainesville, Florida
          • +1 more
          Apr 11, 2022

          Avalglucosidase Alfa Pregnancy Study

          Recruiting
          • Pompe Disease
          • Pregnancy
          • avalglucosidase alfa-NGPT (GZ402666) IV
          • avalglucosidase alfa-NGPT (GZ402666)
          • Bridgewater, New Jersey
            Investigational site worldwide
          Feb 15, 2023

          MPS I, MPS II, MPS IVA Trial in San Francisco (Aldurazyme (laronidase))

          Recruiting
          • MPS I
          • +8 more
          • Aldurazyme (laronidase)
          • San Francisco, California
            University of California
          Apr 21, 2022

          Biomarker for Glycogen Storage Diseases (BioGlycogen)

          Active, not recruiting
          • Fructose Metabolism, Inborn Errors
          • +9 more
            • Rostock, Germany
            • +3 more
            May 12, 2021